WG
CBAY

Winton Group’s Cymabay Therapeutics CBAY Stock Holding History

Winton Group’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17,659
Closed -$64K – 1486
2021
Q3 		$64K Buy
+17,659
New +$69.6K ﹤0.01% 1303
2020
Q3 		– Sell
-58,754
Closed -$205K – 1646
2020
Q2 		$205K Buy
+58,754
New +$170K 0.01% 1355
2020
Q1 		– Sell
-199,381
Closed -$391K – 1577
2019
Q4 		$391K Buy
+199,381
New +$749K 0.01% 1304
2019
Q1 		– Sell
-27,793
Closed -$219K – 1212
2018
Q4 		$219K Buy
27,793
+257
+0.9% +$2.45K ﹤0.01% 779
2018
Q3 		$305K Buy
+27,536
New +$342K 0.01% 812

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return